Prostate cancer trials in China

In China 252 Also abroad 1481

252 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Radical Hypofractionated Radiotherapy for Localized Prostate Cancer
Where
Shanghai
Age
18 years and over
People
20
Run by
Changhai Hospital
See details and how to joinNCT06325774
No phaseTaking people
Hypofractionated Post-prostatectomy Radiotherapy (HYPORT)for Localized Prostate Cancer
Where
Shanghai
People
428
Run by
Changhai Hospital
See details and how to joinNCT06325995
No phaseTaking people
Clinical Study of HIFU for Localized Prostate Cancer
Where
Shanghai
Age
40 years and over
People
60
Run by
RenJi Hospital
See details and how to joinNCT06362577
No phaseTaking people
Efficacy and Safety of Organoid-Based Drug Sensitivity Screening to Guide the Treatment of mCRPC Patients Progressed After First-line Treatment
Where
Guangzhou
Age
18 years to 75 years
People
30
Run by
Sun Yat-sen University
See details and how to joinNCT06529549
Phase 2Not yet taking people in China
Darxicilib Combined With Abiraterone Acetate Tablets (II) for the Treatment of Advanced Metastatic Castration-resistant Prostate Cancer.
Where
Jinan
Age
18 years and over
People
43
Run by
Qilu Hospital of Shandong University
See details and how to joinNCT06500247
Early phase 1Taking people
68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients
Where
Beijing
Age
18 years and over
People
90
Run by
Peking Union Medical College Hospital
See details and how to joinNCT05549024
No phaseNot yet taking people in China
Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy in Prostate Cancer Patients With Lymph Node-positive After Radical Prostatectomy: A Prospective Observational Cohort Study
Where
Beijing
Age
18 years to 80 years
People
108
Run by
Peking University Third Hospital
See details and how to joinNCT06435702
Phase 2Taking people
Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO)
Where
Xiamen
Age
18 years and over
People
40
Run by
The First Affiliated Hospital of Xiamen University
See details and how to joinNCT06387056
Phase 3Taking people
Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients
Where
Nanjing
Age
18 years to 75 years
People
200
Run by
The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT06350825
No phaseTaking people
Adjuvant Hypofractionated Radiotherapy for Prostate Cancer
Where
Shanghai
Age
18 years and over
People
9
Run by
Changhai Hospital
See details and how to joinNCT06335693
Phase 2Taking people
Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
Where
Nanjing
Age
40 years and over
People
102
Run by
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT06305832
No phaseNot yet taking people in China
Neoadjuvant Radiohormonal Therapy for Oligometastatic Prostate Cancer
Where
Guangzhou, Ningbo, Shanghai, Suzhou, Wuxi
Age
18 years to 75 years
People
200
Run by
Changhai Hospital
See details and how to joinNCT05707468
Phase 2Taking people
Clinical Application of Near-infrared Whole Body Heat Shock Multimodal Technique in Treatment of Castration-resistant Prostate Cancer
Where
Hangzhou
Age
18 years to 90 years
People
60
Run by
Pengyuan Liu
See details and how to joinNCT06249750
No phaseNot yet taking people in China
Radiotherapy for Prostate and Oligo-metastatic Lesions in Patients With Low-burden Oligo-metastatic Prostate Cancer
Where
Shanghai
Age
18 years to 75 years
People
30
Run by
Changhai Hospital
See details and how to joinNCT06198387
Phase 2Not yet taking people in China
CVL237 Tablets in the Treatment of Advanced Solid Tumors With PTEN Deficiency
Where
Beijing
Age
18 years to 75 years
People
98
Run by
Convalife (Shanghai) Co., Ltd.
See details and how to joinNCT06183736
Phase 3Taking people
Intermittent Darolutamide Treatment in the Triple Therapy of mHSPC
Where
Nanjing
Age
40 years to 80 years
People
200
Run by
The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT06177015
Phase 3Taking people
Comparing the Efficacy and Safety of Rezvilutamide+ADT+Docetaxel Versus Rezvilutamide +ADT in the mHSPC
Where
Nanjing
Age
40 years to 80 years
People
200
Run by
The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT05983783
Phase 3Taking people
Comparing a 6-month vs Long-term Course of Rezvilutamide With ADT Plus Chemotherapy in mHSPC
Where
Nanjing
Age
18 years and over
People
100
Run by
The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT05956639
Phase 2Not yet taking people in China
Adjutant Apalutamide Plus ADT in Post-RP Patients With High Risk of Recurrence (ARES Study)
Where
Nanjing, Nantong
Age
18 years to 75 years
People
103
Run by
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT05778097
Phase 2Taking people
Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
Where
Nanjing
Age
40 years and over
People
96
Run by
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT05753566
No phaseTaking people
99mTc-P137 SPECT/CT in Prostate Cancer
Where
Xi'an
Age
18 years and over
People
40
Run by
First Affiliated Hospital Xi'an Jiaotong University
See details and how to joinNCT05672485
No phaseTaking people
Safety and Efficacy of Two-step Radical Prostatectomy
Where
Guangzhou
People
30
Run by
Sun Yat-sen University
See details and how to joinNCT05722392
Phase 2Not yet taking people in China
Maximal Cytoreductive Therapies on Post-treatment Metastases in Pts With mHSPC During Apalutamide Plus ADT Treatment
Where
Shanghai
Age
18 years and over
People
47
Run by
Fudan University
See details and how to joinNCT05717582
Phase 2Taking people
Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer
Where
Nanjing
Age
18 years to 80 years
People
900
Run by
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT05406999
Phase 1Taking people
Clinical Study of PSMA-targeted CAR-T Cells in the Treatment of Castration-resistant Prostate Cancer
Where
Xuzhou
Age
18 years to 75 years
People
20
Run by
The Affiliated Hospital of Xuzhou Medical University
See details and how to joinNCT05354375